FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 359:1-3 July 3, 2008 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Interactive Graphic Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

A leading drug company may be poised to win a landmark legal victory next fall. If the drug manufacturer, Wyeth, prevails in a case soon to be argued before the U.S. Supreme Court (Wyeth v. Levine),¹ drug companies could effectively be immunized against state-level tort litigation if their products that have been approved by the Food and Drug Administration (FDA) are later found to be defective.

A medical-device company won such a victory in April. In Riegel v. Medtronic,² the Supreme Court determined that a product-liability lawsuit against Medtronic in a state court was preempted because the device . . . [Full Text of this Article]

Source Information

Dr. Curfman is the executive editor, Dr. Morrissey the managing editor, and Dr. Drazen the editor-in-chief of the Journal.

An interactive timeline is available with the full text of this article at www.nejm.org.

This article has been cited by other articles:

• Annas, G. J. (2009). Good Law from Tragic Facts -- Congress, the FDA, and Preemption. NEJM 361: 1206-1211 [Full Text]  
• Shachar, C., Nair, P. (2009). Recent developments in health law.. J Law Med Ethics 37: 523-530  
• Mazzone, P. J (2009). Give me a sign, any sign. Thorax 64: 737-738 [Full Text]  
• Johnson, A. D., Kavousi, M., Smith, A. V., Chen, M.-H., Dehghan, A., Aspelund, T., Lin, J.-P., van Duijn, C. M., Harris, T. B., Cupples, L. A., Uitterlinden, A. G., Launer, L., Hofman, A., Rivadeneira, F., Stricker, B., Yang, Q., O'Donnell, C. J., Gudnason, V., Witteman, J. C. (2009). Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet 18: 2700-2710 [Abstract] [Full Text]  
• O'Kane, M. J, Pickup, J. (2009). Self-monitoring of blood glucose in diabetes: is it worth it?. Ann Clin Biochem 46: 273-282 [Abstract] [Full Text]  
• Antonini-Canterin, F., Leiballi, E., Enache, R., Popescu, B. A., Rosca, M., Cervesato, E., Piazza, R., Ginghina, C., Nicolosi, G. L. (2009). Hydroxymethylglutaryl Coenzyme-A Reductase Inhibitors Delay the Progression of Rheumatic Aortic Valve Stenosis: A Long-Term Echocardiographic Study. J Am Coll Cardiol 53: 1874-1879 [Abstract] [Full Text]  
• Elahi, M., Asopa, S., Pflueger, A., Hakim, N., Matata, B. (2009). Acute kidney injury following cardiac surgery: impact of early versus late haemofiltration on morbidity and mortality. Eur. J. Cardiothorac. Surg. 35: 854-863 [Abstract] [Full Text]